Caribou Biosciences
Caribou Biosciences Raises $304M in Series C
Caribou Biosciences Raises $304M in Series C
Caribou Biosciences has successfully raised $304M in a Series C at a $1.2B valuation led by RA Capital Management, Baillie Gifford, Redmile Group, Pfizer Ventures.
Company Overview
Caribou Biosciences is a Biotech company headquartered in 2929 Seventh Street, Berkeley, CA 94710, founded in 2011 with 200+ employees.
CRISPR gene editing for cell therapies
Fundraising Details
- Amount Raised: $304M
- Round Type: Series C
- Valuation: $1.2B
- Date: 2024-03-17
- Investors: RA Capital Management, Baillie Gifford, Redmile Group, Pfizer Ventures
About Caribou Biosciences
CRISPR gene editing for cell therapies The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 2929 Seventh Street, Berkeley, CA 94710
- Founded: 2011
- Team Size: 200+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Caribou Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Caribou Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.2B valuation marks an important milestone for Caribou Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Caribou Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-03-17. For more information about Caribou Biosciences, visit their headquarters at 2929 Seventh Street, Berkeley, CA 94710.
Company Info
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free